PDB Short entry for 6HHO HEADER TRANSFERASE 28-AUG-18 6HHO TITLE CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH GSK547 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CELL DEATH PROTEIN RIP,RECEPTOR-INTERACTING PROTEIN 1,RIP-1, COMPND 5 SERINE/THREONINE-PROTEIN KINASE RIP; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RIPK1, RIP, RIP1; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.H.THORPE,P.A.HARRIS REVDAT 2 17-JAN-24 6HHO 1 REMARK REVDAT 1 12-DEC-18 6HHO 0 JRNL AUTH W.WANG,J.M.MARINIS,A.M.BEAL,S.SAVADKAR,Y.WU,M.KHAN, JRNL AUTH 2 P.S.TAUNK,N.WU,W.SU,J.WU,A.AHSAN,E.KURZ,T.CHEN,I.YABOH,F.LI, JRNL AUTH 3 J.GUTIERREZ,B.DISKIN,M.HUNDEYIN,M.REILLY,J.D.LICH, JRNL AUTH 4 P.A.HARRIS,M.K.MAHAJAN,J.H.THORPE,P.NASSAU,J.E.MOSLEY, JRNL AUTH 5 J.LEINWAND,J.A.KOCHEN ROSSI,A.MISHRA,B.AYKUT,M.GLACKEN, JRNL AUTH 6 A.OCHI,N.VERMA,J.I.KIM,V.VASUDEVARAJA,D.ADEEGBE,C.ALMONTE, JRNL AUTH 7 E.BAGDATLIOGLU,D.J.COHEN,K.K.WONG,J.BERTIN,G.MILLER JRNL TITL RIP1 KINASE DRIVES MACROPHAGE-MEDIATED ADAPTIVE IMMUNE JRNL TITL 2 TOLERANCE IN PANCREATIC CANCER. JRNL REF CANCER CELL V. 34 757 2018 JRNL REFN ISSN 1878-3686 JRNL PMID 30423296 JRNL DOI 10.1016/J.CCELL.2018.10.006 REMARK 2 REMARK 2 RESOLUTION. 3.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 8891 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 446 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.49 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.77 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2483 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2320 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2347 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.48 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 136 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4332 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 103.0 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 117.2 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 19.70590 REMARK 3 B22 (A**2) : 25.18900 REMARK 3 B33 (A**2) : -44.89490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.460 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.558 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.907 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.858 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4483 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6041 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1610 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 117 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 620 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4483 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 570 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4878 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.19 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.69 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.31 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HHO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1200011691. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.12 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8924 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.490 REMARK 200 RESOLUTION RANGE LOW (A) : 80.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.13100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.63900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 4ITH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25MM TRIS HCL, 150MM NACL, 1MM DTT, REMARK 280 10% GLYCEROL, PH7.5 AND 4MM GSK547, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 51.32450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 25.41950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 65.18500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 25.41950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 51.32450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 65.18500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -8 REMARK 465 ASP A -7 REMARK 465 TYR A -6 REMARK 465 LYS A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 LYS A 0 REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 PRO A 3 REMARK 465 ASP A 4 REMARK 465 MET A 5 REMARK 465 SER A 6 REMARK 465 LEU A 7 REMARK 465 SER A 25 REMARK 465 GLY A 26 REMARK 465 GLY A 27 REMARK 465 ARG A 177 REMARK 465 GLU A 178 REMARK 465 VAL A 179 REMARK 465 ASP A 180 REMARK 465 GLY A 181 REMARK 465 THR A 182 REMARK 465 ALA A 183 REMARK 465 LYS A 184 REMARK 465 LYS A 185 REMARK 465 ASN A 186 REMARK 465 GLY A 187 REMARK 465 MET B -8 REMARK 465 ASP B -7 REMARK 465 TYR B -6 REMARK 465 LYS B -5 REMARK 465 ASP B -4 REMARK 465 ASP B -3 REMARK 465 ASP B -2 REMARK 465 ASP B -1 REMARK 465 LYS B 0 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 PRO B 3 REMARK 465 ASP B 4 REMARK 465 MET B 5 REMARK 465 SER B 6 REMARK 465 GLU B 19 REMARK 465 SER B 20 REMARK 465 ALA B 21 REMARK 465 GLU B 22 REMARK 465 LEU B 23 REMARK 465 ASP B 24 REMARK 465 SER B 25 REMARK 465 GLY B 26 REMARK 465 GLY B 27 REMARK 465 PHE B 28 REMARK 465 ARG B 177 REMARK 465 GLU B 178 REMARK 465 VAL B 179 REMARK 465 ASP B 180 REMARK 465 GLY B 181 REMARK 465 THR B 182 REMARK 465 ALA B 183 REMARK 465 LYS B 184 REMARK 465 LYS B 185 REMARK 465 ASN B 186 REMARK 465 GLY B 187 REMARK 465 GLY B 188 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 137 -22.09 78.79 REMARK 500 GLU A 175 56.63 -102.40 REMARK 500 ASP A 200 83.57 -160.41 REMARK 500 GLU A 229 18.24 56.56 REMARK 500 CYS B 53 56.77 -153.08 REMARK 500 LYS B 137 -19.29 83.40 REMARK 500 ASP B 138 59.33 -144.47 REMARK 500 ASN B 199 -3.90 69.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G4W A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G4W B 301 DBREF 6HHO A 1 294 UNP Q13546 RIPK1_HUMAN 1 294 DBREF 6HHO B 1 294 UNP Q13546 RIPK1_HUMAN 1 294 SEQADV 6HHO MET A -8 UNP Q13546 INITIATING METHIONINE SEQADV 6HHO ASP A -7 UNP Q13546 EXPRESSION TAG SEQADV 6HHO TYR A -6 UNP Q13546 EXPRESSION TAG SEQADV 6HHO LYS A -5 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP A -4 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP A -3 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP A -2 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP A -1 UNP Q13546 EXPRESSION TAG SEQADV 6HHO LYS A 0 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ALA A 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 6HHO ALA A 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 6HHO ALA A 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 6HHO ALA A 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQADV 6HHO MET B -8 UNP Q13546 INITIATING METHIONINE SEQADV 6HHO ASP B -7 UNP Q13546 EXPRESSION TAG SEQADV 6HHO TYR B -6 UNP Q13546 EXPRESSION TAG SEQADV 6HHO LYS B -5 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP B -4 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP B -3 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP B -2 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ASP B -1 UNP Q13546 EXPRESSION TAG SEQADV 6HHO LYS B 0 UNP Q13546 EXPRESSION TAG SEQADV 6HHO ALA B 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 6HHO ALA B 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 6HHO ALA B 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 6HHO ALA B 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQRES 1 A 303 MET ASP TYR LYS ASP ASP ASP ASP LYS MET GLN PRO ASP SEQRES 2 A 303 MET SER LEU ASN VAL ILE LYS MET LYS SER SER ASP PHE SEQRES 3 A 303 LEU GLU SER ALA GLU LEU ASP SER GLY GLY PHE GLY LYS SEQRES 4 A 303 VAL SER LEU ALA PHE HIS ARG THR GLN GLY LEU MET ILE SEQRES 5 A 303 MET LYS THR VAL TYR LYS GLY PRO ASN CYS ILE GLU HIS SEQRES 6 A 303 ASN GLU ALA LEU LEU GLU GLU ALA LYS MET MET ASN ARG SEQRES 7 A 303 LEU ARG HIS SER ARG VAL VAL LYS LEU LEU GLY VAL ILE SEQRES 8 A 303 ILE GLU GLU GLY LYS TYR SER LEU VAL MET GLU TYR MET SEQRES 9 A 303 GLU LYS GLY ASN LEU MET HIS VAL LEU LYS ALA GLU MET SEQRES 10 A 303 SER THR PRO LEU SER VAL LYS GLY ARG ILE ILE LEU GLU SEQRES 11 A 303 ILE ILE GLU GLY MET ALA TYR LEU HIS GLY LYS GLY VAL SEQRES 12 A 303 ILE HIS LYS ASP LEU LYS PRO GLU ASN ILE LEU VAL ASP SEQRES 13 A 303 ASN ASP PHE HIS ILE LYS ILE ALA ASP LEU GLY LEU ALA SEQRES 14 A 303 SER PHE LYS MET TRP SER LYS LEU ASN ASN GLU GLU HIS SEQRES 15 A 303 ASN GLU LEU ARG GLU VAL ASP GLY THR ALA LYS LYS ASN SEQRES 16 A 303 GLY GLY THR LEU TYR TYR MET ALA PRO GLU HIS LEU ASN SEQRES 17 A 303 ASP VAL ASN ALA LYS PRO THR GLU LYS SER ASP VAL TYR SEQRES 18 A 303 SER PHE ALA VAL VAL LEU TRP ALA ILE PHE ALA ASN LYS SEQRES 19 A 303 GLU PRO TYR GLU ASN ALA ILE ALA GLU GLN GLN LEU ILE SEQRES 20 A 303 MET ALA ILE LYS SER GLY ASN ARG PRO ASP VAL ASP ASP SEQRES 21 A 303 ILE THR GLU TYR CYS PRO ARG GLU ILE ILE SER LEU MET SEQRES 22 A 303 LYS LEU CYS TRP GLU ALA ASN PRO GLU ALA ARG PRO THR SEQRES 23 A 303 PHE PRO GLY ILE GLU GLU LYS PHE ARG PRO PHE TYR LEU SEQRES 24 A 303 SER GLN LEU GLU SEQRES 1 B 303 MET ASP TYR LYS ASP ASP ASP ASP LYS MET GLN PRO ASP SEQRES 2 B 303 MET SER LEU ASN VAL ILE LYS MET LYS SER SER ASP PHE SEQRES 3 B 303 LEU GLU SER ALA GLU LEU ASP SER GLY GLY PHE GLY LYS SEQRES 4 B 303 VAL SER LEU ALA PHE HIS ARG THR GLN GLY LEU MET ILE SEQRES 5 B 303 MET LYS THR VAL TYR LYS GLY PRO ASN CYS ILE GLU HIS SEQRES 6 B 303 ASN GLU ALA LEU LEU GLU GLU ALA LYS MET MET ASN ARG SEQRES 7 B 303 LEU ARG HIS SER ARG VAL VAL LYS LEU LEU GLY VAL ILE SEQRES 8 B 303 ILE GLU GLU GLY LYS TYR SER LEU VAL MET GLU TYR MET SEQRES 9 B 303 GLU LYS GLY ASN LEU MET HIS VAL LEU LYS ALA GLU MET SEQRES 10 B 303 SER THR PRO LEU SER VAL LYS GLY ARG ILE ILE LEU GLU SEQRES 11 B 303 ILE ILE GLU GLY MET ALA TYR LEU HIS GLY LYS GLY VAL SEQRES 12 B 303 ILE HIS LYS ASP LEU LYS PRO GLU ASN ILE LEU VAL ASP SEQRES 13 B 303 ASN ASP PHE HIS ILE LYS ILE ALA ASP LEU GLY LEU ALA SEQRES 14 B 303 SER PHE LYS MET TRP SER LYS LEU ASN ASN GLU GLU HIS SEQRES 15 B 303 ASN GLU LEU ARG GLU VAL ASP GLY THR ALA LYS LYS ASN SEQRES 16 B 303 GLY GLY THR LEU TYR TYR MET ALA PRO GLU HIS LEU ASN SEQRES 17 B 303 ASP VAL ASN ALA LYS PRO THR GLU LYS SER ASP VAL TYR SEQRES 18 B 303 SER PHE ALA VAL VAL LEU TRP ALA ILE PHE ALA ASN LYS SEQRES 19 B 303 GLU PRO TYR GLU ASN ALA ILE ALA GLU GLN GLN LEU ILE SEQRES 20 B 303 MET ALA ILE LYS SER GLY ASN ARG PRO ASP VAL ASP ASP SEQRES 21 B 303 ILE THR GLU TYR CYS PRO ARG GLU ILE ILE SER LEU MET SEQRES 22 B 303 LYS LEU CYS TRP GLU ALA ASN PRO GLU ALA ARG PRO THR SEQRES 23 B 303 PHE PRO GLY ILE GLU GLU LYS PHE ARG PRO PHE TYR LEU SEQRES 24 B 303 SER GLN LEU GLU HET G4W A 301 29 HET G4W B 301 29 HETNAM G4W 6-[4-[(5~{S})-5-[3,5-BIS(FLUORANYL)PHENYL]PYRAZOLIDIN- HETNAM 2 G4W 1-YL]CARBONYLPIPERIDIN-1-YL]PYRIMIDINE-4-CARBONITRILE HETSYN G4W GSK547 FORMUL 3 G4W 2(C20 H20 F2 N6 O) HELIX 1 AA1 LYS A 13 SER A 15 5 3 HELIX 2 AA2 HIS A 56 ARG A 69 1 14 HELIX 3 AA3 LEU A 100 LYS A 105 1 6 HELIX 4 AA4 PRO A 111 LYS A 132 1 22 HELIX 5 AA5 LYS A 140 GLU A 142 5 3 HELIX 6 AA6 PHE A 162 ASN A 170 1 9 HELIX 7 AA7 ALA A 194 LEU A 198 5 5 HELIX 8 AA8 THR A 206 ASN A 224 1 19 HELIX 9 AA9 PRO A 227 ALA A 231 5 5 HELIX 10 AB1 GLU A 234 GLY A 244 1 11 HELIX 11 AB2 ASP A 248 ILE A 252 5 5 HELIX 12 AB3 PRO A 257 TRP A 268 1 12 HELIX 13 AB4 ASN A 271 ARG A 275 5 5 HELIX 14 AB5 THR A 277 LEU A 293 1 17 HELIX 15 AB6 LYS B 13 PHE B 17 5 5 HELIX 16 AB7 HIS B 56 ASN B 68 1 13 HELIX 17 AB8 ASN B 99 LYS B 105 1 7 HELIX 18 AB9 PRO B 111 LYS B 132 1 22 HELIX 19 AC1 LYS B 140 GLU B 142 5 3 HELIX 20 AC2 PHE B 162 GLU B 171 1 10 HELIX 21 AC3 THR B 189 MET B 193 5 5 HELIX 22 AC4 ALA B 194 LEU B 198 5 5 HELIX 23 AC5 THR B 206 ASN B 224 1 19 HELIX 24 AC6 ALA B 233 GLY B 244 1 12 HELIX 25 AC7 ASP B 248 ILE B 252 5 5 HELIX 26 AC8 PRO B 257 TRP B 268 1 12 HELIX 27 AC9 ASN B 271 ARG B 275 5 5 HELIX 28 AD1 THR B 277 GLN B 292 1 16 SHEET 1 AA1 6 ILE A 10 MET A 12 0 SHEET 2 AA1 6 LEU A 78 GLU A 84 1 O VAL A 81 N MET A 12 SHEET 3 AA1 6 LYS A 87 GLU A 93 -1 O VAL A 91 N GLY A 80 SHEET 4 AA1 6 GLY A 40 LYS A 49 -1 N ILE A 43 O MET A 92 SHEET 5 AA1 6 LYS A 30 HIS A 36 -1 N ALA A 34 O MET A 42 SHEET 6 AA1 6 PHE A 17 LEU A 23 -1 N LEU A 18 O PHE A 35 SHEET 1 AA2 3 GLY A 98 ASN A 99 0 SHEET 2 AA2 3 ILE A 144 VAL A 146 -1 O VAL A 146 N GLY A 98 SHEET 3 AA2 3 ILE A 152 ILE A 154 -1 O LYS A 153 N LEU A 145 SHEET 1 AA3 5 ILE B 10 MET B 12 0 SHEET 2 AA3 5 LEU B 78 GLU B 84 1 O VAL B 81 N MET B 12 SHEET 3 AA3 5 LYS B 87 GLU B 93 -1 O SER B 89 N ILE B 82 SHEET 4 AA3 5 GLY B 40 LYS B 49 -1 N TYR B 48 O TYR B 88 SHEET 5 AA3 5 LYS B 30 HIS B 36 -1 N HIS B 36 O GLY B 40 SHEET 1 AA4 2 ILE B 144 VAL B 146 0 SHEET 2 AA4 2 ILE B 152 ILE B 154 -1 O LYS B 153 N LEU B 145 SITE 1 AC1 19 VAL A 31 ILE A 43 LYS A 45 MET A 67 SITE 2 AC1 19 LEU A 70 VAL A 76 LEU A 78 LEU A 90 SITE 3 AC1 19 MET A 92 LEU A 129 VAL A 134 HIS A 136 SITE 4 AC1 19 ILE A 154 ALA A 155 ASP A 156 LEU A 157 SITE 5 AC1 19 LEU A 159 SER A 161 PHE A 162 SITE 1 AC2 15 VAL B 31 LYS B 45 MET B 67 VAL B 76 SITE 2 AC2 15 LEU B 78 LEU B 90 MET B 92 LEU B 129 SITE 3 AC2 15 HIS B 136 ILE B 154 ALA B 155 ASP B 156 SITE 4 AC2 15 LEU B 157 LEU B 159 SER B 161 CRYST1 102.649 130.370 50.839 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009742 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007670 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019670 0.00000